ClinicalTrials.govpublic full text
Clinical Trial of IL - 22BP Safety, Tolerability, and Antitumor Activity in Refractory Solid Tumors.
refractory malignant solid tumors, mrna vaccine, interleukin
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 628574
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.